Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Diabetes Controversies and Conundrums: Tight Glucose Control, First Line Agents, and the Elderly
Track: Educational Sessions (CE)
Program Code: 212-L01
Date: Monday, December 7, 2009
Time: 2:00 PM to 5:00 PM EST
Location: 2101B - Bellini
MEETING PLANNING ASSOCIATE:   Click the plus sign to see more detailed information about each speaker.
 Pamela Stamm, PharmD, BCPS, Associate Professor of Pharmacy Practice, Auburn University
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Jennifer Goldman-Levine, PharmD, CDE, BC-ADM, Associate Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences
 Stuart Haines, PharmD, BC-ADM, Professor and Pharmacotherapy Specialist, University of Maryland School of Pharmacy
 Peggy Odegard, PharmD, BCPS, Associate Professor and Director, Geriatrics Program, University of Washington, School of Pharmacy
 Pamela Stamm, PharmD, BCPS, Associate Professor of Pharmacy Practice, Auburn University
Description
Planned in cooperation with the ASHP Section of Home, Ambulatory, and Chronic Care Practitioners
ACPE Activity #204-000-09-212-L01P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: Pamela L. Stamm, PharmD, CDE,
Associate Professor of Pharmacy Practice, Auburn University, Auburn, AL; and Clinical Pharmacy Specialist, Central Alabama Veteran's Health Care System, Columbus, GA

2:00 p.m. - 2:05 p.m.
Announcements

2:05 p.m. - 2:45 p.m.
Tight Glycemic Control: An Evolving Perspective in Benefits versus Risks
Stuart T. Haines, PharmD, BC-ADM, FASHP,
Professor and Pharmacotherapy Specialist, University of Maryland School of Pharmacy, Baltimore; and Clinical Pharmacy Specialist, West Palm Beach VA Medical Center, West Palm Beach, FL

2:45 p.m. - 2:55 p.m.
Questions, Answers, and Discussion

3:00 p.m. - 3:45 p.m.
First Line Therapy: Orals or Insulin
Jennifer Goldman-Levine,PharmD, CDE,
Associate Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston; and Clinical Pharmacist, Diabetes Educator, Malden Family Medical Center, Malden, MA

3:45 p.m. - 4:00 p.m.
Questions, Answers, and Discussion

4:00 p.m. - 4:50 p.m.
Challenging Conventional Wisdom: Issues with Tight Glycemic Control in the Elderly
Peggy Odegard, PharmD, BCPS,
Associate Professor and Director, Geriatrics Program, University of Washington, School of Pharmacy, Seattle; and Clinical Pharmacist and Diabetes Educator, University of Washington, Department of Medicine, Seattle

4:50 p.m. - 5:00 p.m.
Questions, Answers, and Discussion

Learning Objectives:

LEARNER OUTCOMES:
  • Compare and contrast monotherapy and dual therapy as initial therapy of type 2 diabetes.
  • Discuss the advantages and limitations of insulin as an initial therapy of type 2 diabetes.
  • Discuss the impact of age on A1C goals and selection of a diabetes regimen.
  • Select an appropriate first line agent for treatment of type 2 diabetes.
  • Using the current evidence, justify an A1C goal for a given patient.


Audio Synchronized to PowerPoint
(Code: 212-L01)
Attendee:Free
  
This session is a part of:
Handout Online
View